Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tyndall, A., Gratwohl, A. Blood and marrow stem cell transsplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 19, 643–645 (1997). https://doi.org/10.1038/sj.bmt.1700727
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700727
- Springer Nature Limited
This article is cited by
-
Stem Cell Therapy as a Treatment for Autoimmune Disease—Updates in Lupus, Scleroderma, and Multiple Sclerosis
Current Allergy and Asthma Reports (2021)
-
Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients
Neurology and Therapy (2020)
-
Autologe hämatopoetische Stammzelltransplantation bei systemischer Sklerose
Zeitschrift für Rheumatologie (2020)
-
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)
Bone Marrow Transplantation (2020)
-
Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: Review of Current Status
BioDrugs (2019)